PubMed (GeneRIF) for id: 140564

Year	Number of Results
2008	1
2012	2
2013	3
2014	2
2016	3
2020	1
2024	0

1

Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator.

Takei H, Fukuda H, Pan G, Yamazaki H, Matsumoto T, Kazuma Y, Fujii M, Nakayama S, Kobayashi IS, Shindo K, Yamashita R, Shirakawa K, Takaori-Kondo A, Kobayashi SS. Takei H, et al. Int J Hematol. 2020 Sep;112(3):395-408. doi: 10.1007/s12185-020-02904-y. Epub 2020 Jun 12. Int J Hematol. 2020. PMID: 32533515 Free PMC article.

2

APOBEC3 proteins can copackage and comutate HIV-1 genomes.

Desimmie BA, Burdick RC, Izumi T, Doi H, Shao W, Alvord WG, Sato K, Koyanagi Y, Jones S, Wilson E, Hill S, Maldarelli F, Hu WS, Pathak VK. Desimmie BA, et al. Nucleic Acids Res. 2016 Sep 19;44(16):7848-65. doi: 10.1093/nar/gkw653. Epub 2016 Jul 20. Nucleic Acids Res. 2016. PMID: 27439715 Free PMC article.

3

APOBEC3DE Inhibits LINE-1 Retrotransposition by Interacting with ORF1p and Influencing LINE Reverse Transcriptase Activity.

Liang W, Xu J, Yuan W, Song X, Zhang J, Wei W, Yu XF, Yang Y. Liang W, et al. PLoS One. 2016 Jul 18;11(7):e0157220. doi: 10.1371/journal.pone.0157220. eCollection 2016. PLoS One. 2016. PMID: 27428332 Free PMC article.

4

APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.

Bouzidi MS, Caval V, Suspène R, Hallez C, Pineau P, Wain-Hobson S, Vartanian JP. Bouzidi MS, et al. J Mol Biol. 2016 Aug 28;428(17):3514-28. doi: 10.1016/j.jmb.2016.05.022. Epub 2016 Jun 8. J Mol Biol. 2016. PMID: 27289067

5

APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.

Sato K, Takeuchi JS, Misawa N, Izumi T, Kobayashi T, Kimura Y, Iwami S, Takaori-Kondo A, Hu WS, Aihara K, Ito M, An DS, Pathak VK, Koyanagi Y. Sato K, et al. PLoS Pathog. 2014 Oct 16;10(10):e1004453. doi: 10.1371/journal.ppat.1004453. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25330146 Free PMC article.

6

APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.

Wang Z, Wakae K, Kitamura K, Aoyama S, Liu G, Koura M, Monjurul AM, Kukimoto I, Muramatsu M. Wang Z, et al. J Virol. 2014 Jan;88(2):1308-17. doi: 10.1128/JVI.03091-13. Epub 2013 Nov 13. J Virol. 2014. PMID: 24227842 Free PMC article.

7

Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations.

Duggal NK, Fu W, Akey JM, Emerman M. Duggal NK, et al. Virology. 2013 Sep 1;443(2):329-37. doi: 10.1016/j.virol.2013.05.016. Epub 2013 Jun 10. Virology. 2013. PMID: 23755966 Free PMC article.

8

APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.

Chaipan C, Smith JL, Hu WS, Pathak VK. Chaipan C, et al. J Virol. 2013 Jan;87(1):444-53. doi: 10.1128/JVI.00676-12. Epub 2012 Oct 24. J Virol. 2013. PMID: 23097438 Free PMC article.

9

Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.

Refsland EW, Hultquist JF, Harris RS. Refsland EW, et al. PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12. PLoS Pathog. 2012. PMID: 22807680 Free PMC article.

10

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.

Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF. Zhang W, et al. PLoS One. 2008;3(12):e3963. doi: 10.1371/journal.pone.0003963. Epub 2008 Dec 17. PLoS One. 2008. PMID: 19088851 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year